Announced
Completed
Synopsis
Investment firm Invus, Wexford Capital and HBM-MedFocus led a $18m Series B round in Viseon, a privately held medical device company. "We are very pleased to have the ongoing support from our current investment partners, with confidence underscored by inside-only investor participation and oversubscription. Ongoing advancements in minimally invasive surgical techniques often bring the consequence, and risk of limited visualization. As fundamental as it may seem, enhanced real-time intraoperative visualization projected onto a large high-definition flat panel display will contribute toward clinical outcomes improvement, procedural efficiency, reduced risk of complications, OR staff involvement teaching opportunity and procedure expansion," Jeffrey Valko, Viseon President and CEO.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.